Abstract

Background: Liver cirrhosis is the most common cause of ascites. For cirrhotic ascites that does not respond to diuretics and salt restriction, large-volume paracentesis is an alternative option. Methods: A retrospective cohort study of patients admitted to the Day care unit at King Abdulaziz University Hospital for therapeutic paracentesis of cirrhotic ascites was performed from March 2013-April 2014. The demographic data and results, including the platelet count, hemoglobin level, prothrombin time (PT), international normalized ratio (INR), serum creatinine, serum albumin, and bilirubin levels, were recorded. We recorded all of the bleeding episodes. Results: We recorded 118 admissions for 13 patients. Nine of them were male (69.2%), and the mean age was 58.6 ± 15.8 years. All patients had a Child-Pugh score of C. The platelet count was lower than normal for 78 admissions (66.1%), and the PT was prolonged for 99 admissions (84%). Three episodes of bleeding occurred in our cohort, all of which were mild and controlled by the local application of pressure. One patient required a platelet transfusion for severe thrombocytopenia, low platelets count was associated with elevated creatinine and low albumin levels (P = 0.014 and 0.003, respectively). Similarly, a prolonged PT was associated with low albumin, high bilirubin, low platelet, and high creatinine levels (P = 0.013, < 0.001, = 0.006, and < 0.001, respectively). Conclusions: Large-volume paracentesis is associated with only a small risk of bleeding in patients with cirrhotic ascites, and a transfusion of fresh frozen plasma (FFP) and platelets is not needed for the majority of patients.

Highlights

  • Liver cirrhosis is the most common cause of ascites [1]

  • This study was conducted to determine whether abdominal paracentesis was related to bleeding episodes in patients with refractory cirrhotic ascites who were admitted to the day care unit for therapeutic paracentesis

  • The inclusion criteria consisted of patients with liver cirrhosis who were under the care of the hepatology department, had confirmed diuretic-refractory or intractable cirrhotic ascites and had been admitted to the day care unit at King Abdulaziz University Hospital Jeddah for therapeutic paracentesis

Read more

Summary

Introduction

Liver cirrhosis is the most common cause of ascites [1]. The standard treatment for cirrhotic ascites is salt restriction and diuresis with spironolactone and furosemide [2] [3]. Most patients with advanced liver cirrhosis have coagulation disorders due to hepatic dysfunction, platelet dysfunction and/or thrombocytopenia due to hypersplenism [6]-[8] These factors are thought to place cirrhotic patients with therapeutic paracentesis, especially those with advanced cirrhosis at risk of bleeding [6] [7]. Methods: A retrospective cohort study of patients admitted to the Day care unit at King Abdulaziz University Hospital for therapeutic paracentesis of cirrhotic ascites was performed from March 2013-April 2014. Conclusions: Large-volume paracentesis is associated with only a small risk of bleeding in patients with cirrhotic ascites, and a transfusion of fresh frozen plasma (FFP) and platelets is not needed for the majority of patients

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call